PHIO Q4 2017 Earnings — Phio Pharmaceuticals Corp. Revenue & Financial Results | Market Cap Arena

PHIOPhio Pharmaceuticals Corp.

$13M

Q4 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$15,000

Gross Profit

-$1M-7926.7% margin

Operating Income

-$2M-13273.3% margin

Net Income

-$2M-13346.7% margin

EPS (Diluted)

$-5003.06

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$38,000

Balance Sheet

Total Assets

$4M

Total Liabilities

$2M

Stockholders' Equity

$2M

Cash & Equivalents

$4M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$15,000	$0	—
Gross Profit	-$1M	-$1M	+9.0%
Operating Income	-$2M	-$2M	+14.9%
Net Income	-$2M	-$2M	+14.4%